Optimising preoperative diagnosis in phyllodes tumour of the breast

Journal of Clinical Pathology

Volumn 59, Issue 5, 2006, Pages 454-459

  Jacklin, R K ^a   Ridgway, P F ^b   Ziprin, P ^b   Healy, V ^b   Hadjiminas, D ^a   Darzi, A ^b  

^a ST MARY S HOSPITAL   (United Kingdom)

^b IMPERIAL COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

KI 67 ANTIGEN; PROTEIN P53; TUMOR MARKER;

ASPIRATION BIOPSY; BREAST FIBROADENOMA; CELL PROLIFERATION; CYSTOSARCOMA PHYLLOIDES; CYTOPATHOLOGY; DIAGNOSTIC ACCURACY; DIAGNOSTIC IMAGING; FLOW CYTOMETRY; HUMAN; IMMUNOHISTOCHEMISTRY; INTERMETHOD COMPARISON; MAMMOGRAPHY; NEEDLE BIOPSY; PREOPERATIVE EVALUATION; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVIEW; TUMOR DIAGNOSIS; TUMOR DIFFERENTIATION;

ADULT; AGE FACTORS; BIOPSY; BREAST; BREAST NEOPLASMS; DIAGNOSIS, DIFFERENTIAL; FEMALE; FIBROADENOMA; HUMANS; PATIENT SELECTION; PHYLLODES TUMOR;

EID: 33646420864     PISSN: 00219746     EISSN: None     Source Type: Journal    
DOI: 10.1136/jcp.2005.025866     Document Type: Review

References (82)

1. Ridgway PF, Jacklin RK, Ziprin P, et al. Perioperative diagnosis of cystosarcoma phyllodes of the breast may be enhanced by MIB-1 index. J Surg Res 2004;122:83-8.
2. El-Naggar AK, Mackay B, Sneige N, et al. Stromal neoplasms of the breast: a comparative flow cytometric study. J Surg Oncol 1990;44:151-6.
3. Chelius M. Neue Jahrbucher der Teutschen Medicin and Chirurgie. Heidelberg: Naegele und Puchelt, 1827:517-21.
4. Rowell MD, Perry RR, Hsiu JG, et al. Phyllodes tumors. Am J Surg 1993;165:376-9.
5. Rosen PP, Oberman HA. Tumors of the mammary gland. Washington, DC: Armed Forces Institute of Pathology, 1993:107-13.
6. Azzopardi JG, Ahmed A, Millis RR. Problems in breast pathology. Major Probl Pathol 1979;11:346-64.
7. Salvadori B, Cusumano F, Del Bo R, et al. Surgical treatment of phyllodes tumors of the breast. Cancer 1989;63:2532-6.
8. Pietruszka M, Barnes L. Cystosarcoma phyllodes: a clinicopathologic analysis of 42 cases. Cancer 1978;41:1974-83.
9. Kok KY, Telesinghe PU, Yapp SK. Treatment and outcome of cystosarcoma phyllodes in Brunei: a 13-year experience. J R Coll Surg Edinb 2001;46:198-201.
10. Kario K, Maeda S, Mizuno Y, et al. Phyllodes tumor of the breast: a clinicopathologic study of 34 cases. J Surg Oncol 1990;45:46-51.
11. Chaney AW, Pollack A, Marsha D, et al. Primary treatment of cystosarcoma phyllodes of the breast. Cancer 2000;89:1502-10.
12. Kapiris I, Nasiri N, A'Hern R, et al. Outcome and predictive factors of local recurrence and distant metastases following primary surgical treatment of high-grade malignant phyllodes tumours of the breast. Eur J Surg Oncol 2001;27:723-30.
13. Cohn-Cedermark G, Rutqvist LE, Rosendahl I, et al. Prognostic factors in cystosarcoma phyllodes. A clinicopathologic study of 77 patients. Cancer 1991;68:2017-22.
14. Moffat CJ, Pinder SE, Dixon AR, et al. Phyllodes tumours of the breast: a clinicopathological review of thirty-two cases. Histopathology 1995;27:205-18.
15. de Roos WK, Kaye P, Dent DM. Factors leading to local recurrence or death after surgical resection of phyllodes tumours of the breast. Br J Surg 1999;86:396-9.
16. Mangi A, Smith B, Gadd M, et al. Surgical management of phyllodes tumours. Arch Surg 1999;134:487-91.
17. Barth RJ. Histologic features predict local recurrence after breast conserving therapy of phyllodes tumors. Breast Cancer Res Treat 1999;57:291-5.
18. Chan YJ, Chen BF, Chang CL, et al. Expression of p53 protein and Ki-67 antigen in phyllodes tumor of the breast. J Chin Med Assoc 2004;67:3-8.
19. Gatalica Z, Finkelstein S, Lucio E, et al. p53 protein expression and gene mutation in phyllodes tumors of the breast. Pathol Res Pract 2001;197:183-7.
20. Chu JS. Prognostic factors in phyllodes tumor of the breast: are immunohistochemical biomarkers useful? (comment). J Chin Med Assoc 2004;67:1-2.
21. Aranda FI, Laforga JB, Lopez JI. Phyllodes tumor of the breast. An immunohistochemical study of 28 cases with special attention to the role of myofibroblasts. Pathol Res Pract 1994;190:474-81.
22. Barwijuk-Machala M, Musiatowicz B, Cylwik J, et al. AgNOR, Ki-67 and PCNA expression in fibroepithelial tumours of the breast in correlation with morphological features. Folia Morphol (Warsz) 2004;63:133-5.
23. Dacic S, Kounelis S, Kouri E, et al. Immunohistochemical profile of cystosarcoma phyllodes of the breast: a study of 23 cases. Breast J 2002;8:376-81.
24. Kuenen-Boumeester V, Henzen-Logmans SC, Timmermans MM, et al. Altered expression of p53 and its regulated proteins in phyllodes tumours of the breast. J Pathol 1999;189:169-75.
25. Shpitz B, Bomstein Y, Sternberg A, et al. Immunoreactivity of p53, Ki-67, and c-erbB-2 in phyllodes tumors of the breast in correlation with clinical and morphologic features. J Surg Oncol 2002;79:86-92.
26. Suo Z, Nesland JM. Phyllodes tumor of the breast: EGFR family expression and relation to clinicopathological features. Ultrastruct Pathol 2000;24:371-81.
27. Umekita Y, Yoshida H. Immunohistochemical study of MIB1 expression in phyllodes tumor and fibroadenoma. Pathol Int 1999;49:807-10.
28. Umekita Y, Yoshida H. Immunohistochemical study of hormone receptor and hormone-regulated protein expression in phyllodes tumour: comparison with fibroadenoma. Virchows Arch 1998;433:311-14.
29. Feakins RM, Wells CA, Young KA, et al. Platelet-derived growth factor expression in phyllodes tumors and fibroadenomas of the breast. Hum Pathol 2000;31:1214-22.
30. Rao BR, Meyer JS. Progesterone receptor in cystosarcoma phyllodes. Arch Surg 1977;112:620-2.
31. el-Naggar AK, Ro JY, McLemore D, et al. DNA content and proliferative activity of cystosarcoma phyllodes of the breast. Potential prognostic significance. Am J Clin Pathol 1990;93:480-5.
32. Layfield LJ, Hart J, Neuwirth H, et al. Relation between DNA ploidy and the clinical behavior of phyllodes tumors. Cancer 1989;64:1486-9.
33. Grimes MM. Cystosarcoma phyllodes of the breast: histologic features, flow cytometric analysis, and clinical correlations. Mod Pathol 1992;5:232-9.
34. Keelan PA, Myers JL, Wold LE, et al. Phyllodes tumor: clinicopathologic review of 60 patients and flow cytometric analysis in 30 patients. Hum Pathol 1992;23:1048-54.
35. Niezabitowski A, Lackowska B, Rys J, et al. Prognostic evaluation of proliferative activity and DNA content in the phyllodes tumor of the breast: immunohistochemical and flow cytometric study of 118 cases. Breast Cancer Res Treat 2001;65:77-85.
36. Palko MJ, Wang SE, Shackney SE, et al. Flow cytometric S fraction as a predictor of clinical outcome in cystosarcoma phyllodes. Arch Pathol Lab Med 1990;114:949-52.
37. Dal Cin P, Moreman P, De Wever I, et al. Is i(1)(q10) a chromosome marker in phyllodes tumor of the breast?(comment). Cancer Genet Cytogenet 1995;83:174-5.
38. Kasami M, Vnencak-Jones CL, Manning S, et al. Monoclonality in fibroadenomas with complex histology and phyllodal features. Breast Cancer Res Treat 1998;50:185-91.
39. Lamb J, Anderson TJ, Dixon MJ, et al. Role of fine needle aspiration cytology in breast cancer screening. J Clin Pathol 1987;40:705-9.
40. Chua CL, Thomas A, Ng BK. Cystosarcoma phyllodes: a review of surgical options. Surgery 1989;105:141-7.
41. Stebbing JF, Nash AG. Diagnosis and management of phyllodes tumour of the breast: experience of 33 cases at a specialist centre. Ann R Coll Surg Engl 1995;77:181-4.
42. Umpleby HC, Moore I, Royle GT, et al. An evaluation of the preoperative diagnosis and management of cystosarcoma phyllodes. Ann R Coll Surg Engl 1989;71:285-8.
43. Reinfuss M, Mitus J, Duda K, et al. The treatment and prognosis of patients with phyllodes tumor of the breast: an analysis of 170 cases. Cancer 1996;77:910-16.
44. Komenaka IK, El-Tamer M, Pile-Spellman E, et al. Core needle biopsy as a diagnostic tool to differentiate phyllodes tumor from fibroadenoma. Arch Surg 2003;138:987-90.
45. Bernstein L, Deapen D, Ross RK. The descriptive epidemiology of malignant cystosarcoma phyllodes tumors of the breast. Cancer 1993;71:3020-4.
46. Jorge Blanco A, Vargas Serrano B, Rodriguez Romero R, et al. Phyllodes tumors of the breast. Eur Radiol 1999;9:356-60.
47. Feder JM, de Paredes ES, Hogge JP, et al. Unusual breast lesions: radiologic-pathologic correlation. Radiographics 1999;19:11-26.
48. Cosmacini P, Veronesi P, Zurrida S, et al. Mammography in the diagnosis of phyllodes tumors of the breast. Analysis of 99 cases. Radiol Med (Torino) 1991;82:52-5.
49. Cole-Beuglet C, Soriano R, Kurtz AB, et al. Ultrasound, x-ray mammography, and histopathology of cystosarcoma phylloides. Radiology 1983;146:481-6.
50. Kinoshita T, Fukutomi T, Kubochi K. Magnetic resonance imaging of benign phyllodes tumors of the breast. Breast J 2004;10:232-6.
51. Tse GMK, Cheung HS, Pang L-M, et al. Characterization of lesions of the breast with proton MR spectroscopy: comparison of carcinomas, benign lesions, and phyllodes tumors. Am J Roentgenol 2003;181:1267-72.
52. Katayama N, Inoue Y, Ichikawa T, et al. Increased activity in benign phyllodes tumor on Tc-99m MDP scintimammography. Clin Nucl Med 2000;25:551-2.
53. Ohta H, Komibuchi T, Nishio T, et al. Technetium-99m-sestamibi scintimammography of benign and malignant phyllodes tumors. Ann Nucl Med 1997;11:37-9.
54. Page JE, Williams JE. The radiological features of phylloides tumour of the breast with clinico-pathological correlation. Clin Radiol 1991;44:8-12.
55. Buchberger W, Strasser K, Heim K, et al. Phylloides tumor: findings on mammography, sonography, and aspiration cytology in 10 cases. Am J Roentgenol 1991;157:715-19.
56. Liberman L, Bonaccio E, Hamele-Bena D, et al. Benign and malignant phyllodes tumors: mammographic and sonographic findings. Radiology 1996;198:121-4.
57. Chhieng DC, Cangiarella JF, Waisman J, et al. Fine-needle aspiration cytology of spindle cell lesions of the breast. Cancer 1999;87:359-71.
58. Stanley MW, Tani EM, Rutqvist LE, et al. Cystosarcoma phyllodes of the breast: a cytologic and clinicopathologic study of 23 cases. Diagn Cytopathol 1989;5:29-34.
59. Simi U, Moretti D, Iacconi P, et al. Fine needle aspiration cytopathology of phyllodes tumor. Differential diagnosis with fibroadenoma. Acta Cytol 1988;32:63-6.
60. Shabalova IP, Chemeris GJ, Ermilova VD, et al. Phyllodes tumour: cytologic and histologic presentation of 22 cases, and immunohistochemical demonstration of p53. Cytopathology 1997;8:177-87.
61. Shabb NS. Phyllodes tumor. Fine needle aspiration cytology of eight cases. Acta Cytol 1997;41:321-6.
62. Deen SA, McKee GT, Kissin MW. Differential cytologic features of fibroepithelial lesions of the breast. Diagnostic Cytopathol 1999;20:53-6.
63. Bhattarai S, Kapila K, Verma K. Phyllodes tumor of the breast. A cytohistologic study of 80 cases. Acta Cytol 2000;44:790-6.
64. Krishnamurthy S, Ashfaq R, Shin HJ, et al. Distinction of phyllodes tumor from fibroadenoma: a reappraisal of an old problem. Cancer 2000;90:342-9.
65. Scolyer RA, McKenzie PR, Achmed D, et al. Can phyllodes tumours of the breast be distinguished from fibroadenomas using fine needle aspiration cytology? Pathology 2001;33:437-43.
66. Badhe BA, Iyengar KR, Alva N. A study of fibroepithelial tumours of the breast. Indian J Cancer 2002;39:91-6.
67. Jayaram G, Sthaneshwar P. Fine-needle aspiration cytology of phyllodes tumors. Diagnostic Cytopathol 2002;26:222-7.
68. Shimizu K, Korematsu M. Phyllodes tumor of the breast. A cytomorphologic approach based on evaluation of epithelial cluster architecture. Acta Cytol 2002;46:332-6.
69. Ellis IO, Humphreys S, Michell M, et al. Guidelines for non-operative diagnostic procedures and reporting in breast cancer screening. Sheffield: NHS Cancer Screening Programmes, 2001.
70. Rosen PP. Fibroepithelial neoplasms. In: Rosen's breast pathology, 2nd ed. Philadelphia: Lippincott-Raven, 1996:163-200.
71. Florentine BD, Cobb CJ, Frankel K, et al. Core needle biopsy. A useful adjunct to fine-needle aspiration in select patients with palpable breast lesions. Cancer 1997;81:33-9.
72. Norris HJ, Taylor HB. Relationship of histologic features to behavior of cystosarcoma phyllodes. Analysis of ninety-four cases. Cancer 1967;20:2090-9.
73. Murad TM, Hines JR, Beal J, et al. Histopathological and clinical correlations of cystosarcoma phyllodes. Arch Pathol Lab Med 1988;112:752-6.
74. Barbosa ML, Ribeiro EMSF, Silva GF, et al. Cytogenetic findings in phyllodes tumor and fibroadenomas of the breast. Cancer Genet Cytogenet 2004;154:156-9.
75. Erhan Y, Zekioglu O, Ersoy O, et al. p53 and Ki-67 expression as prognostic factors in cystosarcoma phyllodes. Breast J 2002;8:38-44.
76. Feakins RM, Mulcahy HE, Nickols CD, et al. p53 expression in phyllodes tumours is associated with histological features of malignancy but does not predict outcome. Histopathology 1999;35:162-9.
77. Millar EK, Beretov J, Marr P, et al. Malignant phyllodes tumours of the breast display increased stromal p53 protein expression. Histopathology 1999;34:491-6.
78. Kim CJ, Kim WH. Patterns of p53 expression in phyllodes tumours of the breast-an immunohistochemical study. J Korean Med Sci 1993;8:325-8.
79. Kleer CG, Giordano TJ, Braun T, et al. Pathologic, immunohistochemical, and molecular features of benign and malignant phyllodes tumors of the breast. Mod Pathol 2001;14:185-90.
80. Scholzen T, Gerdes J. The Ki-67 protein: from the known and the unknown. J Cell Physiol 2000;182:311-22.
81. Kocova L, Skalova A, Fakan F, et al. Phyllodes tumour of the breast: immunohistochemical study of 37 tumours using MIB1 antibody. Pathol Res Pract 1998;194:97-104.
82. Kaya R, Pestereli HE, Erdogan G, et al. Proliferating activity in differential diagnosis of benign phyllodes tumor and cellular fibroadenomas: is it helpful? Pathol Oncol Res 2001;7:213-16.